Tagged with Manufacturing,

Switzerland As the largest privately owned pharmaceutical company in Switzerland, IBSA remains committed to continuing to invest and manufacture in Switzerland. Head of Swiss Business Operations Maleša Ulrico Sidjanski, MSc ETH, discusses the company’s current priorities, values, and upcoming investments.   What other mid-sized multinational pharmaceutical companies present in over 80…

Switzerland Managing volatility – the CEO of Acino, a Swiss pharmaceutical player, elaborates on the company’s unique strategy based on its significant expertise in volatile and uncertain key markets within their regions. Most of your career has been spent with mid-cap and big pharmaceutical companies. Three years ago, you decided to…

Greece As the President of the Panhellenic Union of Pharmaceutical Industries (PEF), Theodore Tryfon shares the mission of the association, the main challenges plaguing the sector, as well as the measures in place to mitigate the difficult economic times and elevate the Greek brand in the upcoming years. As an introduction…

Greece Dimitris Anagnostakis is emblematic of Boehringer Ingelheim’s corporate values as evidenced by his 26-year loyalty to the company promoting the advancement of innovation. As the General Manager spearheading the only multinational company with manufacturing operations in Greece, he shares his insights on the company’s robust portfolio, navigating the difficulties of…

Taiwan Kao Su-Chin Chang, founder and chairman of Weidar Chemical and Pharmaceutical, describes the robust development and international expansion of this historical domestic pharmaceutical manufacturer and the company’s enduring commitment to maintaining the excellence of its manufacturing capacity, which has allowed Weidar to establish itself as one of the foremost generics…

Ireland The strong flow of FDI into Ireland has led to a vibrant ecosystem of Irish service providers, who have grown up servicing the needs of pharma MNCs. Working for FDI clients has put Irish companies to the test and pushed them to work to the highest standards. “Top global pharma…

Ireland David Anchell, cofounder and CEO of Camida, a bespoke chemical supplier and distributor based in Ireland, details the exciting story of Camida’s founding, the specialist sourcing services they provide, their ‘can-do’ attitude of never saying no to clients, and his insights on the development of the Irish pharmaceutical landscape in…

Ireland Donal O’Callaghan, founder and CEO of Callaghan Engineering, an Irish engineering and construction firm, tells us what motivated him to break into the pharma market in 1990, the changes in the industry he has seen, and his ambition to position Callaghan Engineering as an engineering house of choice. You founded…

Mexico Salomon Rayek, CEO at Sinbiotik, explains how the company managed to adapt its business model to the industry trends and showcases the added value of Sinbiotik when offering high quality, cost-effective and fully regulated APIs manufactured locally. Could you please introduce yourself to our international audience as well as the…

Luxembourg Miriam Steimer, as employee number one of the Fast-track diagnostics success story, provides a thorough analysis into the company’s global footprint, the scope of operations in Luxembourg with both manufacturing and R&D activities, and the significance of the “made in Luxembourg” label. Finally, Ms Steimer shares FTD’s remarkably high levels…

Switzerland With 40 years of history in Switzerland, B Braun serves every hospital in the country and operates three distinct production sites. CEO Madeleine Stöckli discusses her strategy for improving productivity and finding opportunities for growth. Could you please briefly introduce yourself and B Braun Switzerland to our readers? B Braun…

Mexico This chart gives an insight into the phenomenal importance of the pharmaceutical industry to Mexico, in terms of both monetary value and employment created. Public, private, and out of pocket healthcare coverage in Mexico. The growth of the Mexican pharma industry by patented, generic and OTC segments. API Manufacturing compared…